Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7745R | — |
Expired dose given; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number 7745R, expiry date 22-AUG-2025) for prophylaxis. On 28-AUG-2025, the patient received Kinrix. On 28-AUG-2025, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: Expired dose given). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-SEP-2025 The healthcare professional called in to request data about the validity of an expired dose of Kinrix which was given in 28th August 2022, but the dose expired on 22nd August 2025 which led to expired vaccine used. The patient was a 4 year old. The vaccine administration facility was the same as primary reporter.